Bloomberg News (9/14, Feeley) reports that C.R. Bard, Inc. has “agreed to settle a woman’s claims that one of its vaginal-mesh implants caused internal problems before a trial set for this month in New Jersey.” Specifically, Bard agreed to pay an undisclosed sum for serious urinary problems caused by Bard’s Avaulta Plus insert. This is the second vaginal-mesh case Bard settled since a federal jury in Charleston, West Virginia, ordered the device maker last month to pay $2 million.
Bard “faces more than 8,000 claims over the Avaulta line of inserts, which women allege can cause organ damage and make sexual intercourse painful when the devices erode,” along with similar claims against Johnson & Johnson, Endo Health Solutions Inc., and Boston Scientific Corp.
Zoll, Kranz & Borgess, LLC, a pharmaceutical drug and device litigation firm, represents victims with transvaginal mesh injuries. ZKB Law knows which manufacturers are currently involved in litigation, and they can provide a complimentary evaluation to determine the specifics of your case. For more information about your legal rights, contact our experienced pharmaceutical drug and device attorneys by calling toll-free 888-841-9623 today.